Soda & Sativa: How This Company’s Strategy Resembles Coca Cola

You walk into a Chipotle restaurant, famished and thirsty. It’s all you’ve been thinking about since this morning.

“White or brown rice?” The young employee asks, with a smile.

You genuinely can’t wait for the assembly line to be over so you can command in your most confident voice: “And a large Coke Zero, please.”

Customers dig Chipotle’s Coke selection because they get so many options to choose from. Chipotle digs it because the customers dig it. And Coca Cola Corp (NYSE: KO) digs it because it means literally no extra work for them, but rather enhanced profits, branding, and an addition to the overall bottom line. They supply the syrup; the machine does the rest.

In this way, the company is able to capitalize on variations in customer preferences without physically having to modify or deal with creating beverage brands. It’s brilliant, and it’s one of the things that has kept Coca Cola ahead of the pack.

We’ve stumbled across a cannabis (thats Wall Street lingo for marijuana) company – a publicly traded company – that is looking to do something similar but for cannabis, edibles, and the marijuana industry as a whole. Now pay attention.

Through distribution partnerships and licensing agreements, MariMed Inc. (OTCQB: MRMD) is contracting with cannabis producers to manufacture and sell premium quality branded products that consumers love– And Investors will too. 

In MariMed’s business model, the Company simply provides licensees with the proprietary ingredients, the formulation process, the branded packaging and the specialized machinery to manufacture the products– the licensees provide the cannabis oils according to the product’s required specifications at its facility.  Similar to how Coco Cola provides restaurants with equipment and syrup, they just add water, and in the case with MariMed they “just add cannabis!”

Now, you may think that comparing an internationally recognized beverage company to weed could be a bit of a stretch, but consider this:

  • According to the most recent research from Ameri Research, the legal marijuana market was worth $14.3 billion in 2016 and is expected to grow to $63.5 billion by the year 2024.
  • Further, Pew Research estimates that more than 70 percent of the U.S population supports legalizing cannabis with 73 percent of millenials supporting legalization. 

With their product lines Kalm Fusion and Betty’s Eddies already a smash hit, the Company will soon be able to put operations – and thus profits – on cruise control. Some examples of their product line include:

Kalm Corn. “Kalming buttery bliss without the butter.”

It’s all natural, microwavable, and sprinkled with Pink Himalayan salt, known for its mineral and vibrational qualities and lighter sodium content. It’s delicious, affordable, and comes in a pretty good-looking package, to boot.

Kalm Fusion also has a few other branded products under their banner, check them out here:

Betty’s Eddies Berry Bombs

Betty’s Eddies Berry Bombs are the bomb. They feature the same handcrafted goodness of the chews, but in a greater dosage. Made with real cherries, strawberries and blueberries, these treats are infused with naturally extracted THC for a heavenly adventure.

For the full line of Betty’s Eddies have a look at their site: 

Once operations are set up, the initial manufacturing is done under MariMed’s supervision, and over time, the licensed staff is trained and certified by MariMed.   

When the products are made and sold the licensee pays MariMed (OTCQB: MRMD) up to a 25% of wholesale as a royalty—which is precisely why it could be a very explosive catalyst as license and royalty fees are highly accretive to the bottom line—very high margin.

Coca Cola was able to scale their business globally, and make money and profits for Shareholders by reducing the congestion, overhead, paperwork, and bureaucracy involved in distribution to focus on increasing the bottom line. We see MariMed Inc. doing precisely that, but in an exploding industry.

MariMed (OTCQB MRMD) has lined up, or is in the process of lining up, strategic licensees and manufacturers in state licensed facilities across the Country which could provide a solid distribution network for Kalm Fusion and Betty’s Eddies to hundreds of dispensaries.

This network approach will be a valuable asset of MRMD for not only their current brands, but other new and innovative cannabis products they may wish to acquire or develop. 

We feel MRMD’s branded edible products could eventually be in the majority of the major cannabis markets based on their initial reception.

We know your mouth could perhaps again be watering, not just at the products listed here, but at the potential for profits that could be seen from the Company’s shares. Take action today before the rest of the street finds out. Added guac doesn’t come cheap.

The Cannabis Investor is always researching new trade ideas which have the makings for large market moves. Traders are urged to follow our parent outlet, The Wealthy Venture Capitalist & The Cannabis Investor, on social media (see below) to stay apprised. We are an anti-email media outlet, and as such will only be releasing our reports/ updates/ news through Twitter and Facebook, as well as newswire.


Join the largest Cannabis Investing page on Facebook:

To receive text Message alerts when new articles are released click here:

Join our Email list:

Follow us on Instagram:

Follow us on Twitter: @CannaInvestor
Like us on


This report/release/profile is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation unless otherwise stated below. The Wealthy Venture Capitalist and its employees are not a Registered Investment Advisors, Broker Dealers or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Sometimes human error can attribute to honest mistakes in reporting on issues regarding public companies and overall capital markets, and as such we are not responsible for the complete accuracy in these reports as the reader is required to verify all statements to ensure they are completely accurate. The Wealthy Venture Capitalist’s controlling parent company has been compensated $6,500 per month for 12 months by MariMed Inc. (MRMD). The Wealthy Venture Capitalist’s controlling parent company has also been compensated 325,000 restricted shares by MariMed Inc. (MRMD). The Wealthy Venture Capitalist encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled through their website, news releases, and corporate filings, or is available from public sources and The Wealthy Venture Capitalist makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. The Private Securities Litigation Reform Act of 1995 provides investors a ‘safe harbor’ in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be “forward looking statements”. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as “projects,” “foresee,” “expects,” “will,” “anticipates,” “estimates,” “believes,” “understands,” or that by statements indicating certain actions “may,” “could,” or “might” occur. Understand there is no guarantee past performance will be indicative of future results. Past Performance is based on the security’s previous day closing price and the high of day price during our promotional coverage. Readers must visit our website at in order to view our entire disclaimer which covers most of the risks, biases and liability releases to have a full understanding after reading this article.

Leave a Reply

Your email address will not be published. Required fields are marked *

pour la musculation tamoxifen buylivraison anonyme, prix favorable As a rule, the infection occurs during penetrative sexual intercourse buy metronidazole no prescription moist environment and can remain viable. cialis 20mg rezeptfreider Wirkstoff des Arzneimittels wird nicht verlassen, Zweifel an der Wirksamkeit der Pillen ein bewährtes Medikament zur Behandlung von BPH in einer Dosierung von 10 mg, die Möglichkeit gibt, ein neues Potential des Penis, um zu versuchen buy Retin AThis drug will no doubt help to solve the problem with acne in young people from 16 years, thanks to the active ingredient of this cream you will experience relief, people will stop laughing at you Diagnosticare la causa della disfunzione erettilecomprar cilaiscosì spesso il trattamento può comportare molteplici tecniche. Comprar cialis en línea

Wealthy Venture Capitalist